Avantis International Small Cap Value ETF vs DexCom, Inc. — how do they compare? Avantis International Small Cap Value ETF trades at $109.61, while DexCom, Inc. trades at $89.2 (market cap $33.79B). Which is the better fit depends on your goals.
| AVDV | DXCM | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $110.40 | $89.53 |
52-Week Low | $83.89 | $54.84 |
Market Cap | — | $33.79B |
Enterprise Value | — | $33.24B |
Trailing returns across standard periods
AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →